Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
about
Toward a better understanding of the comparatively high prostate cancer incidence rates in UtahThe National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.Prostate cancer screening: waiting for Godot.Pattern of testicular biopies as seen in a tertiary institution in nnewi, southeast NigeriaWhy men with prostate cancer want wider access to prostate specific antigen testing: qualitative study.Clinical Evidence: Non-metastatic prostate cancer.Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries.Watchful waiting as a treatment option for localized prostate cancer in the PSA era.Reverse stage shift at a tertiary care center: escalating risk in men undergoing radical prostatectomy.Prostate cancer management: (1) an update on localised diseasePrognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.PSA testing: are patients aware of what lies ahead?Epidemiology and statistical methods in prediction of patient outcome.The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study.Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancerDietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk.Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.Contemporary measures for the assessment of health-related quality of life in prostate cancer.When 'dueling technologies' are mistaken for progress.Practice patterns of Korean urologists for screening and managing prostate cancer according to PSA level.Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.Cancer incidence and mortality, 1973-1995: a report card for the U.S.Early detection and aggressive treatment of prostate cancer: groping in the dark.Localised prostate cancer: can we do better? There have been some advances in local control, but little impact on survival.Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.[High-grade prostatic intraepithelial neoplasia: the only accepted prostate cancer precursor lesion].Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based studyProstate cancer
P2860
Q24800113-BF86831A-E973-4E56-B1D3-BE037813D422Q31995706-5BD6B165-BA34-431C-8118-2140F3686988Q34030164-273E3AB4-E3C7-47F6-B4DE-96B02BF17010Q34077551-861BBB15-7D6A-4506-82D4-45CD62396128Q34133027-AFAD1AD7-FC17-4CC7-84CC-D19E0D697CE4Q34191176-413E1387-686A-4BFE-BDCE-2A9E232E1D47Q34703693-80BD4027-E34F-4BB0-A615-22B1F109BA84Q34703699-E3015F48-5399-4913-B366-000E77E7E0DCQ35072945-83E0B776-CFE6-4D9A-9A6A-5343B8D4C234Q35235435-6B01A65A-2502-4906-9081-62B7C743BAFFQ35517935-B45DFE0A-67B0-482F-A303-E48843887A05Q35832300-42DB57B8-1C87-4B34-98DF-43E25C940449Q35968794-A92B1142-1862-4ADF-A58A-35E360BDB3A3Q36194975-29465255-E0C4-45BF-80B2-EA8CDDFCAF05Q36238011-5B6E060F-B0CC-4911-9597-8FC68CF17813Q36900805-F15CBC31-1A41-44D9-BF86-A916758A5855Q37357993-D354461C-D483-403E-AF14-21F7B72FB5DEQ37384669-3BF0927D-475A-4BE0-9257-4375EC4E8AC4Q37609254-BEF5561E-5ABF-4084-A5A0-E99F26900053Q37876958-C06EC638-48FE-428A-9063-A954B8BC006BQ38052876-AF915CE7-1EC7-4E3A-A8A8-254E1B9C6D77Q38491112-0355AF96-04E1-47D8-9D07-6189FA06C0C2Q40867044-B4631D86-D01F-40C5-ABFF-7ADCEC9E84E8Q42345809-7C5A65E8-78CE-4021-9151-F7EB7949E9A3Q42765839-27C9951B-5F44-4559-BAD2-D30824C84365Q45909143-2C4D833A-BEC1-4D3B-B521-4295DA08C637Q50661098-FF65B5DC-990B-48F1-898A-8BD4557529D6Q53283064-B2FCDBED-051A-4E3D-B0EB-CBE7CCE2F630Q56765034-94AEA695-0810-4DE8-9C82-DDAD307FF387Q57656183-6424F5E9-2700-4AD2-AC45-C47B3BDF1D0D
P2860
Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Prostate carcinoma incidence a ...... screening and early detection.
@en
Prostate carcinoma incidence a ...... screening and early detection.
@nl
type
label
Prostate carcinoma incidence a ...... screening and early detection.
@en
Prostate carcinoma incidence a ...... screening and early detection.
@nl
prefLabel
Prostate carcinoma incidence a ...... screening and early detection.
@en
Prostate carcinoma incidence a ...... screening and early detection.
@nl
P2860
P1433
P1476
Prostate carcinoma incidence a ...... screening and early detection.
@en
P2093
Brawley OW
P2860
P304
P356
10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3
P407
P577
1997-11-01T00:00:00Z